Antiparasitic therapy
- PMID: 21628620
- PMCID: PMC3104918
- DOI: 10.4065/mcp.2011.0203
Antiparasitic therapy
Abstract
Parasitic diseases affect more than 2 billion people globally and cause substantial morbidity and mortality, particularly among the world's poorest people. This overview focuses on the treatment of the major protozoan and helminth infections in humans. Recent developments in antiparasitic therapy include the expansion of artemisinin-based therapies for malaria, new drugs for soil-transmitted helminths and intestinal protozoa, expansion of the indications for antiparasitic drug treatment in patients with Chagas disease, and the use of combination therapy for leishmaniasis and human African trypanosomiasis.
Similar articles
-
Drugs for parasitic infections.Med Lett Drugs Ther. 1986 Jan 31;28(706):9-16. Med Lett Drugs Ther. 1986. PMID: 3945225 No abstract available.
-
The chemotherapy of parasitic infections.J Parasitol. 1986 Feb;72(1):45-61. J Parasitol. 1986. PMID: 3519918 Review. No abstract available.
-
[The therapy of the more common intestinal parasitic diseases].Policlinico Prat. 1969 Jan 6;76(1):1-13. Policlinico Prat. 1969. PMID: 5763595 Italian. No abstract available.
-
[Pulmonary changes caused by parasites].Pneumonol Alergol Pol. 1991;59(11-12):51-9. Pneumonol Alergol Pol. 1991. PMID: 1843902 Review. Polish. No abstract available.
-
Treatment of parasitic infections of travelers and immigrants.N Engl J Med. 1984 Feb 2;310(5):298-304. doi: 10.1056/NEJM198402023100507. N Engl J Med. 1984. PMID: 6361567 Review. No abstract available.
Cited by
-
The Indian Society of Critical Care Medicine Position Statement on the Management of Sepsis in Resource-limited Settings.Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S4-S19. doi: 10.5005/jp-journals-10071-24682. Epub 2024 Aug 10. Indian J Crit Care Med. 2024. PMID: 39234230 Free PMC article.
-
Synthesis and anthelmintic activity of novel thiosemicarbazide and 1,2,4-triazole derivatives: In vitro, in vivo, and in silico study.J Adv Res. 2024 Jun;60:57-73. doi: 10.1016/j.jare.2023.07.004. Epub 2023 Jul 17. J Adv Res. 2024. PMID: 37467960 Free PMC article.
-
Nematicidal Characterization of Solanum nigrum and Mentha arvensis Leaf Extracts Using Caenorhabditis elegans as a Model Organism.ACS Omega. 2023 Feb 16;8(10):9454-9463. doi: 10.1021/acsomega.2c08124. eCollection 2023 Mar 14. ACS Omega. 2023. PMID: 36936282 Free PMC article.
-
SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity.Front Cardiovasc Med. 2023 Jan 4;9:1013262. doi: 10.3389/fcvm.2022.1013262. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36684586 Free PMC article.
-
Evaluation of Anthelmintic and Anti-Inflammatory Activity of 1,2,4-Triazole Derivatives.Molecules. 2022 Jul 13;27(14):4488. doi: 10.3390/molecules27144488. Molecules. 2022. PMID: 35889357 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) Guidelines for treatment of malaria in the United States. http://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf Accessed April 29, 2011
-
- Dondorp A, Nosten F, Stepniewska K, Day N, White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366:717-725 - PubMed
-
- Centers for Disease Control and Prevention (CDC) Notice to readers: new medication for severe malaria available under an investigational new drug protocol. Morb Mortal Wkly Rep. 2007;56(30):769-770 http://www.cdc.gov/Mmwr/preview/mmwrhtml/mm5630a5.htm Accessed April 29, 2011
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
